Biomea Fusion Stock Options

BMEA Stock  USD 10.77  0.21  1.91%   
Biomea Fusion's option chain provides insight into all available option contracts written on Biomea Fusion's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Biomea Fusion's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Biomea option contract.

In The Money vs. Out of Money Option Contracts on Biomea Fusion

Analyzing Biomea Fusion's in-the-money options over time can help investors to take a profitable long position in Biomea Fusion regardless of its overall volatility. This is especially true when Biomea Fusion's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Biomea Fusion's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Biomea Fusion's stock while costing only a fraction of its price.
Biomea Fusion's latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 111.91 with a put-to-call open interest ratio of 0.17 over 22 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-05-17. The current put volume is at 5, with calls trading at the volume of 55. This yields a 0.09 put-to-call volume ratio. The Biomea Fusion option chain provides detailed quote and price information for the current Biomea Fusion option contracts. It shows all of Biomea Fusion's listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2024-05-17 Option Contracts

Biomea Fusion option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Biomea Fusion's lending market. For example, when Biomea Fusion's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Biomea Fusion, he or she must hedge the risk by shorting Biomea Fusion stock over its option's life.
The chart above shows Biomea Fusion's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Biomea Fusion's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Biomea Fusion's option, there is no secondary market available for investors to trade.
Biomea Fusion's stock options are financial instruments that give investors the right to buy or sell shares of Biomea Fusion common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Biomea stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Biomea Fusion's stock price goes up or down, the stock options follow.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomea Fusion. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.
Please note that buying 'in-the-money' options on Biomea Fusion lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Biomea Fusion's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Biomea Fusion contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Biomea Stock moves the wrong way.
At present, Biomea Fusion's Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 14.8 M, whereas Total Stockholder Equity is forecasted to decline to about 101.6 M.

Biomea Fusion In The Money Call Balance

When Biomea Fusion's strike price is surpassing the current stock price, the option contract against Biomea Fusion stock is said to be in the money. When it comes to buying Biomea Fusion's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Biomea Fusion are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Biomea Current Options Market Mood

Biomea Fusion's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Biomea Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Biomea Fusion's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Biomea Fusion's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Biomea Fusion's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current Biomea contract

Base on the Rule 16, the options market is currently suggesting that Biomea Fusion will have an average daily up or down price movement of about 6.99% per day over the life of the 2024-05-17 option contract. With Biomea Fusion trading at USD 10.77, that is roughly USD 0.75. If you think that the market is fully incorporating Biomea Fusion's daily price movement you should consider buying Biomea Fusion options at the current volatility level of 111.91%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Biomea Fusion options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Biomea calls. Remember, the seller must deliver Biomea Fusion stock to the call owner when a call is exercised.

Biomea Fusion Option Chain

When Biomea Fusion's strike price is surpassing the current stock price, the option contract against Biomea Fusion stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Biomea Fusion's option chain is a display of a range of information that helps investors for ways to trade options on Biomea. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Biomea. It also shows strike prices and maturity days for a Biomea Fusion against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Call
2024-05-17 CALL at $2.50.95790.004402024-05-178.2 - 10.60.0In
Call
2024-05-17 CALL at $5.00.9230.017502024-05-174.5 - 8.30.0In
Call
2024-05-17 CALL at $7.50.82890.039602024-05-173.2 - 5.40.0In
Call
2024-05-17 CALL at $10.00.67160.0858122024-05-170.1 - 4.21.75In
Call
2024-05-17 CALL at $12.50.35830.13241922024-05-170.35 - 0.650.6Out
Call
2024-05-17 CALL at $15.00.17050.081815042024-05-170.25 - 0.30.25Out
Call
2024-05-17 CALL at $30.00.06750.021122024-05-170.0 - 0.20.15Out
 Put
2024-05-17 PUT at $10.0-0.29830.1355742024-05-170.5 - 0.650.55Out
 Put
2024-05-17 PUT at $12.5-0.6640.14155172024-05-171.95 - 2.62.0In
 Put
2024-05-17 PUT at $15.0-0.84750.0808702024-05-173.9 - 4.53.9In
 Put
2024-05-17 PUT at $17.5-0.80760.0584162024-05-176.1 - 6.93.65In
 Put
2024-05-17 PUT at $20.0-0.73840.047412024-05-178.6 - 11.05.15In
 Put
2024-05-17 PUT at $22.5-0.74380.041502024-05-1711.2 - 13.50.0In
 Put
2024-05-17 PUT at $25.0-0.74550.037502024-05-1713.8 - 16.00.0In
 Put
2024-05-17 PUT at $30.0-0.77670.032302024-05-1718.6 - 21.00.0In

Biomea Total Stockholder Equity

Total Stockholder Equity

101.58 Million

At present, Biomea Fusion's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Biomea Fusion without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Ceiling Movement Now

   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Module

Biomea Fusion Corporate Management

Elected by the shareholders, the Biomea Fusion's board of directors comprises two types of representatives: Biomea Fusion inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biomea. The board's role is to monitor Biomea Fusion's management team and ensure that shareholders' interests are well served. Biomea Fusion's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biomea Fusion's outside directors are responsible for providing unbiased perspectives on the board's policies.
Juan MDChief OfficerProfile
Caroline DupontSenior ContractsProfile
Naomi CretcherChief OfficerProfile
Heow TanChief OfficerProfile
Stephan MDChief OfficerProfile
Franco ValleCFO OfficerProfile
Ravi UpasaniExecutive PropertyProfile

Already Invested in Biomea Fusion?

The danger of trading Biomea Fusion is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biomea Fusion is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biomea Fusion. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biomea Fusion is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Biomea Fusion offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomea Fusion's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomea Fusion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomea Fusion Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomea Fusion. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.
Note that the Biomea Fusion information on this page should be used as a complementary analysis to other Biomea Fusion's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Complementary Tools for Biomea Stock analysis

When running Biomea Fusion's price analysis, check to measure Biomea Fusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomea Fusion is operating at the current time. Most of Biomea Fusion's value examination focuses on studying past and present price action to predict the probability of Biomea Fusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomea Fusion's price. Additionally, you may evaluate how the addition of Biomea Fusion to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Is Biomea Fusion's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomea Fusion. If investors know Biomea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomea Fusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.44)
Return On Assets
(0.48)
Return On Equity
(0.84)
The market value of Biomea Fusion is measured differently than its book value, which is the value of Biomea that is recorded on the company's balance sheet. Investors also form their own opinion of Biomea Fusion's value that differs from its market value or its book value, called intrinsic value, which is Biomea Fusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomea Fusion's market value can be influenced by many factors that don't directly affect Biomea Fusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomea Fusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomea Fusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomea Fusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.